Contract SPE2DP21P0676
Emergent Biosolutions Canada Inc · Department Of Defense · June 3, 2021
Emergent Biosolutions Canada Inc was awarded a federal contract by Department Of Defense (Defense Logistics Agency) on June 3, 2021 for $123,000 of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. It uses firm fixed-price contract pricing.
Contract details
- PIID
- SPE2DP21P0676
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- June 3, 2021
Description
8508231182!REACTIVE SKIN DECON
Modification timeline
-
June 3, 2021Base award$123.2K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $51 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $91 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $32 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $1.1K |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $22 |
| Cardinal Health, Inc. | Department Of Defense | December 31, 2025 | $23 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract SPE2DP21P0676?
Contract SPE2DP21P0676 is a federal contract awarded to Emergent Biosolutions Canada Inc by Department Of Defense on June 3, 2021 for $123,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract SPE2DP21P0676?
Emergent Biosolutions Canada Inc won contract SPE2DP21P0676 from Department Of Defense.
How much is contract SPE2DP21P0676 worth?
Contract SPE2DP21P0676 has obligated $123,000 to date.